R1 RCM Inc. (RCM)
USD 14.31
(0.0%)
USD 14.31
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 147.9 Million USD | 4830.0% |
| 2022 | 3 Million USD | -97.94% |
| 2021 | 145.7 Million USD | 82.13% |
| 2020 | 80 Million USD | -29.02% |
| 2019 | 112.7 Million USD | 470.72% |
| 2018 | -30.4 Million USD | -10.55% |
| 2017 | -27.5 Million USD | -109.23% |
| 2016 | 297.9 Million USD | 318.97% |
| 2015 | -136.04 Million USD | -5.74% |
| 2014 | -128.65 Million USD | -163.03% |
| 2013 | 204.1 Million USD | 208.64% |
| 2012 | -187.87 Million USD | -490.96% |
| 2011 | 48.05 Million USD | 115.32% |
| 2010 | 22.31 Million USD | 27.06% |
| 2009 | 17.56 Million USD | 527.99% |
| 2008 | 2.79 Million USD | 682.71% |
| 2007 | -480 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 15.8 Million USD | -75.08% |
| 2024 Q1 | 8 Million USD | -83.71% |
| 2024 Q2 | 63.4 Million USD | 692.5% |
| 2023 Q4 | 49.1 Million USD | 19.17% |
| 2023 Q1 | 33.7 Million USD | -21.99% |
| 2023 Q3 | 41.2 Million USD | 72.38% |
| 2023 Q2 | 23.9 Million USD | -29.08% |
| 2023 FY | 147.9 Million USD | 4830.0% |
| 2022 Q3 | 18.5 Million USD | -62.7% |
| 2022 FY | 3 Million USD | -97.94% |
| 2022 Q4 | 43.2 Million USD | 133.51% |
| 2022 Q1 | 57.7 Million USD | 14.94% |
| 2022 Q2 | 49.6 Million USD | -14.04% |
| 2021 Q1 | 36.8 Million USD | 209.24% |
| 2021 Q2 | 27.6 Million USD | -25.0% |
| 2021 Q3 | 31.1 Million USD | 12.68% |
| 2021 Q4 | 50.2 Million USD | 61.41% |
| 2021 FY | 145.7 Million USD | 82.13% |
| 2020 Q3 | 10.6 Million USD | -57.77% |
| 2020 FY | 80 Million USD | -29.02% |
| 2020 Q1 | 32.4 Million USD | 126.57% |
| 2020 Q2 | 25.1 Million USD | -22.53% |
| 2020 Q4 | 11.9 Million USD | 12.26% |
| 2019 FY | 112.7 Million USD | 470.72% |
| 2019 Q1 | 7.4 Million USD | 89.74% |
| 2019 Q3 | 23.6 Million USD | 90.32% |
| 2019 Q2 | 12.4 Million USD | 67.57% |
| 2019 Q4 | 14.3 Million USD | -39.41% |
| 2018 Q3 | -5.8 Million USD | 67.23% |
| 2018 Q2 | -17.7 Million USD | -63.89% |
| 2018 FY | -30.4 Million USD | -10.55% |
| 2018 Q1 | -10.8 Million USD | -191.89% |
| 2018 Q4 | 3.9 Million USD | 167.24% |
| 2017 Q3 | -5.1 Million USD | 50.0% |
| 2017 Q1 | -8.5 Million USD | -130.9% |
| 2017 FY | -27.5 Million USD | -109.23% |
| 2017 Q4 | -3.7 Million USD | 27.45% |
| 2017 Q2 | -10.2 Million USD | -20.0% |
| 2016 Q3 | 61.42 Million USD | 188.06% |
| 2016 Q4 | 27.5 Million USD | -55.21% |
| 2016 Q1 | 278.72 Million USD | 2452.86% |
| 2016 FY | 297.9 Million USD | 318.97% |
| 2016 Q2 | -69.75 Million USD | -125.03% |
| 2015 Q1 | -49.86 Million USD | -57.94% |
| 2015 Q4 | 10.91 Million USD | 119.91% |
| 2015 Q3 | -54.84 Million USD | -29.78% |
| 2015 Q2 | -42.25 Million USD | 15.25% |
| 2015 FY | -136.04 Million USD | -5.74% |
| 2014 Q4 | -31.57 Million USD | -314.12% |
| 2014 Q3 | 14.74 Million USD | 154.22% |
| 2014 Q2 | -27.19 Million USD | 67.87% |
| 2014 Q1 | -84.63 Million USD | -949.92% |
| 2014 FY | -128.65 Million USD | -163.03% |
| 2013 Q1 | -42.46 Million USD | 78.26% |
| 2013 FY | 204.1 Million USD | 208.64% |
| 2013 Q3 | -60.94 Million USD | -120.48% |
| 2013 Q4 | 9.95 Million USD | 116.34% |
| 2013 Q2 | 297.55 Million USD | 800.72% |
| 2012 Q2 | -1.3 Million USD | -155.8% |
| 2012 Q3 | 6.4 Million USD | 589.98% |
| 2012 Q1 | 2.34 Million USD | -89.44% |
| 2012 Q4 | -195.32 Million USD | -3147.6% |
| 2012 FY | -187.87 Million USD | -490.96% |
| 2011 Q3 | 12.22 Million USD | -7.57% |
| 2011 Q4 | 22.19 Million USD | 81.53% |
| 2011 Q1 | 401 Thousand USD | -95.66% |
| 2011 FY | 48.05 Million USD | 115.32% |
| 2011 Q2 | 13.22 Million USD | 3199.0% |
| 2010 FY | 22.31 Million USD | 27.06% |
| 2010 Q2 | 7.43 Million USD | 534.3% |
| 2010 Q4 | 9.23 Million USD | 106.03% |
| 2010 Q3 | 4.48 Million USD | -39.72% |
| 2010 Q1 | 1.17 Million USD | -85.14% |
| 2009 FY | 17.56 Million USD | 527.99% |
| 2009 Q2 | 2.91 Million USD | 1380.26% |
| 2009 Q3 | 6.98 Million USD | 139.26% |
| 2009 Q4 | 7.88 Million USD | 12.96% |
| 2009 Q1 | -228 Thousand USD | 28.3% |
| 2008 Q3 | 3.51 Million USD | 0.0% |
| 2008 Q4 | -318 Thousand USD | -109.04% |
| 2008 FY | 2.79 Million USD | 682.71% |
| 2007 FY | -480 Thousand USD | 0.0% |
| 2000 Q4 | -4.2 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 71.71 Million USD | -106.247% |
| GE HealthCare Technologies Inc. | 2.43 Billion USD | 93.926% |
| Sharecare, Inc. | -96.47 Million USD | 253.304% |
| Progyny, Inc. | 62.18 Million USD | -137.843% |
| Aclarion, Inc. | -4.87 Million USD | 3133.236% |
| CareMax, Inc. | -656.15 Million USD | 122.541% |
| Simulations Plus, Inc. | 6.13 Million USD | -2312.331% |
| CareCloud, Inc. | -47.11 Million USD | 413.913% |
| Forian Inc. | -5.59 Million USD | 2743.426% |
| Bullfrog AI Holdings, Inc. Warrants | -5.36 Million USD | 2855.46% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.36 Million USD | 2855.46% |
| Minerva Surgical, Inc. | -30.89 Million USD | 578.656% |
| Omnicell, Inc. | -34.86 Million USD | 524.171% |
| Definitive Healthcare Corp. | -329.8 Million USD | 144.845% |
| Zhongchao Inc. | -13.28 Million USD | 1213.386% |
| Accolade, Inc. | -114.45 Million USD | 229.223% |
| Streamline Health Solutions, Inc. | -19.64 Million USD | 852.787% |
| Ontrak, Inc. | -20.67 Million USD | 815.357% |
| SOPHiA GENETICS SA | -74.82 Million USD | 297.659% |
| Spok Holdings, Inc. | 21.22 Million USD | -596.721% |
| Privia Health Group, Inc. | 20.64 Million USD | -616.257% |
| EUDA Health Holdings Limited | -3.96 Million USD | 3833.855% |
| HeartBeam, Inc. | -15.31 Million USD | 1065.783% |
| GeneDx Holdings Corp. | -163.66 Million USD | 190.369% |
| TruBridge, Inc. | -42.6 Million USD | 447.151% |
| Nutex Health, Inc. | -31.77 Million USD | 565.479% |
| Renalytix Plc | -29.6 Million USD | 599.527% |
| Sharecare, Inc. | -96.47 Million USD | 253.304% |
| Health Catalyst, Inc. | -126.89 Million USD | 216.551% |
| 10x Genomics, Inc. | -265.32 Million USD | 155.742% |
| GoodRx Holdings, Inc. | -27 Million USD | 647.636% |
| SCWorx Corp. | -1.45 Million USD | 10295.345% |
| Schrödinger, Inc. | -177.44 Million USD | 183.348% |
| HealthEquity, Inc. | 128.13 Million USD | -15.426% |
| HealthStream, Inc. | 16.01 Million USD | -823.279% |
| MSP Recovery, Inc. | -559.87 Million USD | 126.417% |
| Augmedix, Inc. | -18.77 Million USD | 887.582% |
| BrightSpring Health Services, Inc. Common Stock | 147.18 Million USD | -0.489% |
| Ontrak, Inc. | -20.67 Million USD | 815.357% |
| SHL Telemedicine Ltd. | -9 Million USD | 1742.239% |
| CareCloud, Inc. | -47.11 Million USD | 413.913% |
| Premier, Inc. | 157.08 Million USD | 5.848% |
| Certara, Inc. | -40.77 Million USD | 462.731% |
| GeneDx Holdings Corp. | -163.66 Million USD | 190.369% |
| OneMedNet Corporation | -8.37 Million USD | 1866.128% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 147.18 Million USD | -0.489% |
| EUDA Health Holdings Limited | -3.96 Million USD | 3833.855% |
| HeartBeam, Inc. | -15.31 Million USD | 1065.783% |
| CareCloud, Inc. | -47.11 Million USD | 413.913% |
| Mangoceuticals, Inc. | -9.21 Million USD | 1704.315% |
| CareMax, Inc. | -656.15 Million USD | 122.541% |
| Healthcare Triangle, Inc. | -11.34 Million USD | 1403.313% |
| National Research Corporation | 40.04 Million USD | -269.334% |
| Aclarion, Inc. | -4.87 Million USD | 3133.236% |
| OptimizeRx Corporation | -26.4 Million USD | 660.191% |